COVID-19 – business continuity update

March 23, 2020

As the COVID-19 situation continues to evolve and impact every aspect of society, TSG Consulting has acted swiftly to implement the measures necessary to safeguard the health and safety of all our employees and to provide continuity to our clients.

TSG continues to provide high-quality regulatory and scientific guidance to the biocide, antimicrobials, medical, agricultural, chemical and consumer sectors. Along with our sister companies within Science Group, we are proud to be helping clients bring products to market to help mitigate the spread of the virus and protect public health.

We are continuing to emphasize social distancing and are balancing this with home working / teleworking, where appropriate and as necessary. TSG’s regulatory and scientific teams are set up with VPN capability, giving secure access to project resources and enabling us to provide an uninterrupted service.

Our experts continue to keep clients informed of regulatory updates across Europe and North America as events unfold, providing strategic guidance to help companies respond to them. Our latest coronavirus-related Advisories are also available via our website: COVID-19 – Regulatory updates

As we all adapt to a new working normal, please do call or email your usual contact at TSG with any question or concern that you may have or just for a status update. We can also be reached by email at [email protected]

We wish you, your families and colleagues a safe passage through this challenging period.

Daryl Thomas, MD – TSG Europe & Erin Tesch, Senior VP & MD – TSG North America